Asahi Songwon Colors Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 6, 2025, 8:12 pm

Competitors of Asahi Songwon Colors Ltd

All Competitor Stocks of Asahi Songwon Colors Ltd

Quarterly Result

Last Updated: August 2, 2025, 12:05 am

Below is a detailed analysis of the quarterly data for Asahi Songwon Colors Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 149.88 Cr.. The value appears to be declining and may need further review. It has decreased from 152.75 Cr. (Mar 2025) to 149.88 Cr., marking a decrease of 2.87 Cr..
• For Expenses, as of Jun 2025, the value is 139.34 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 135.68 Cr. (Mar 2025) to 139.34 Cr., marking an increase of 3.66 Cr..
• For Operating Profit, as of Jun 2025, the value is 10.54 Cr.. The value appears to be declining and may need further review. It has decreased from 17.07 Cr. (Mar 2025) to 10.54 Cr., marking a decrease of 6.53 Cr..
• For OPM %, as of Jun 2025, the value is 7.03%. The value appears to be declining and may need further review. It has decreased from 11.18% (Mar 2025) to 7.03%, marking a decrease of 4.15%.
• For Other Income, as of Jun 2025, the value is 1.46 Cr.. The value appears strong and on an upward trend. It has increased from 0.61 Cr. (Mar 2025) to 1.46 Cr., marking an increase of 0.85 Cr..
• For Interest, as of Jun 2025, the value is 3.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.84 Cr. (Mar 2025) to 3.14 Cr., marking a decrease of 0.70 Cr..
• For Depreciation, as of Jun 2025, the value is 4.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.66 Cr. (Mar 2025) to 4.64 Cr., marking a decrease of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.22 Cr.. The value appears to be declining and may need further review. It has decreased from 9.18 Cr. (Mar 2025) to 4.22 Cr., marking a decrease of 4.96 Cr..
• For Tax %, as of Jun 2025, the value is 38.86%. The value appears to be increasing, which may not be favorable. It has increased from 25.05% (Mar 2025) to 38.86%, marking an increase of 13.81%.
• For Net Profit, as of Jun 2025, the value is 2.59 Cr.. The value appears to be declining and may need further review. It has decreased from 6.87 Cr. (Mar 2025) to 2.59 Cr., marking a decrease of 4.28 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.68. The value appears to be declining and may need further review. It has decreased from 6.48 (Mar 2025) to 2.68, marking a decrease of 3.80.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:41 am

Growth

Last Updated: September 4, 2025, 11:45 pm

Balance Sheet

Last Updated: October 10, 2025, 1:40 pm

Below is a detailed analysis of the balance sheet data for Asahi Songwon Colors Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 243.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2024) to 243.00 Cr., marking an increase of 19.00 Cr..
• For Borrowings, as of Mar 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 197.00 Cr. (Mar 2024) to 167.00 Cr., marking a decrease of 30.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 162.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 138.00 Cr. (Mar 2024) to 162.00 Cr., marking an increase of 24.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 584.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 570.00 Cr. (Mar 2024) to 584.00 Cr., marking an increase of 14.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 305.00 Cr.. The value appears to be declining and may need further review. It has decreased from 306.00 Cr. (Mar 2024) to 305.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 11.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 278.00 Cr.. The value appears strong and on an upward trend. It has increased from 253.00 Cr. (Mar 2024) to 278.00 Cr., marking an increase of 25.00 Cr..
• For Total Assets, as of Mar 2025, the value is 584.00 Cr.. The value appears strong and on an upward trend. It has increased from 570.00 Cr. (Mar 2024) to 584.00 Cr., marking an increase of 14.00 Cr..

Notably, the Reserves (243.00 Cr.) exceed the Borrowings (167.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Asahi Songwon Colors Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.76. This value is within the healthy range. It has decreased from 17.01 (Mar 24) to 16.76, marking a decrease of 0.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 16.76. This value is within the healthy range. It has decreased from 17.01 (Mar 24) to 16.76, marking a decrease of 0.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 30.23. This value is within the healthy range. It has increased from 27.03 (Mar 24) to 30.23, marking an increase of 3.20.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.37. It has increased from 199.86 (Mar 24) to 216.37, marking an increase of 16.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.37. It has increased from 199.86 (Mar 24) to 216.37, marking an increase of 16.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 477.09. It has increased from 361.61 (Mar 24) to 477.09, marking an increase of 115.48.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 51.08. This value is within the healthy range. It has increased from 17.88 (Mar 24) to 51.08, marking an increase of 33.20.
• For PBIT / Share (Rs.), as of Mar 25, the value is 35.16. This value is within the healthy range. It has increased from 4.11 (Mar 24) to 35.16, marking an increase of 31.05.
• For PBT / Share (Rs.), as of Mar 25, the value is 21.19. This value is within the healthy range. It has increased from 15.19 (Mar 24) to 21.19, marking an increase of 6.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 14.30. This value is within the healthy range. It has increased from 13.27 (Mar 24) to 14.30, marking an increase of 1.03.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.76. This value is within the healthy range. It has decreased from 17.01 (Mar 24) to 16.76, marking a decrease of 0.25.
• For PBDIT Margin (%), as of Mar 25, the value is 10.70. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 10.70, marking an increase of 5.76.
• For PBIT Margin (%), as of Mar 25, the value is 7.36. This value is below the healthy minimum of 10. It has increased from 1.13 (Mar 24) to 7.36, marking an increase of 6.23.
• For PBT Margin (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 10. It has increased from 4.20 (Mar 24) to 4.44, marking an increase of 0.24.
• For Net Profit Margin (%), as of Mar 25, the value is 2.99. This value is below the healthy minimum of 5. It has decreased from 3.66 (Mar 24) to 2.99, marking a decrease of 0.67.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.51. This value is below the healthy minimum of 8. It has decreased from 4.70 (Mar 24) to 3.51, marking a decrease of 1.19.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.74. This value is below the healthy minimum of 15. It has decreased from 8.50 (Mar 24) to 7.74, marking a decrease of 0.76.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.40. This value is within the healthy range. It has increased from 1.35 (Mar 24) to 11.40, marking an increase of 10.05.
• For Return On Assets (%), as of Mar 25, the value is 3.34. This value is below the healthy minimum of 5. It has decreased from 3.48 (Mar 24) to 3.34, marking a decrease of 0.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.29 (Mar 24) to 0.22, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.64. This value is within the healthy range. It has decreased from 0.83 (Mar 24) to 0.64, marking a decrease of 0.19.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.96. It has increased from 0.76 (Mar 24) to 0.96, marking an increase of 0.20.
• For Current Ratio (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 1.5. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 24) to 0.83, marking an increase of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.55. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 6.55, marking an increase of 3.00.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 2.98. This value is below the healthy minimum of 20. It has increased from 2.94 (Mar 24) to 2.98, marking an increase of 0.04.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.52. This value is below the healthy minimum of 20. It has decreased from 1.62 (Mar 24) to 1.52, marking a decrease of 0.10.
• For Earning Retention Ratio (%), as of Mar 25, the value is 97.02. This value exceeds the healthy maximum of 70. It has decreased from 97.06 (Mar 24) to 97.02, marking a decrease of 0.04.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.48. This value exceeds the healthy maximum of 70. It has increased from 98.38 (Mar 24) to 98.48, marking an increase of 0.10.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.66. This value is within the healthy range. It has increased from 1.68 (Mar 24) to 3.66, marking an increase of 1.98.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. It has increased from 0.20 (Mar 24) to 2.02, marking an increase of 1.82.
• For Enterprise Value (Cr.), as of Mar 25, the value is 577.47. It has decreased from 606.46 (Mar 24) to 577.47, marking a decrease of 28.99.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 1.42 (Mar 24) to 1.03, marking a decrease of 0.39.
• For EV / EBITDA (X), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 28.78 (Mar 24) to 9.59, marking a decrease of 19.19.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.89 (Mar 24) to 0.69, marking a decrease of 0.20.
• For Retention Ratios (%), as of Mar 25, the value is 97.01. This value exceeds the healthy maximum of 70. It has decreased from 97.05 (Mar 24) to 97.01, marking a decrease of 0.04.
• For Price / BV (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has decreased from 1.62 (Mar 24) to 1.53, marking a decrease of 0.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.89 (Mar 24) to 0.69, marking a decrease of 0.20.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness